Multiple Myeloma is a B-cell lymphocyte malignancy. In the last few years, there has been a continually increasing interest in the clinical and pathophysiological information on Multiple Myeloma and related diseases, a ccompanying a dramatic change in the understanding of the biology of the disease itself, diagnostic procedures and the recent therapeutic approaches.